STATNews & Politicsnews

STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data needed

Tuesday, April 28, 2026Elaine ChenView original

Eli Lilly's deal with Profluent, Erasca's RAS-targeting cancer pill, and more biotech news today

Read the full article on the original site.